Cargando…
A TP53-associated gene signature for prediction of prognosis and therapeutic responses in lung squamous cell carcinoma
The tumor-suppressor gene tumor protein p53 (TP53) is one of the most commonly mutated genes in human lung cancer, and TP53 mutations are associated with a worsened prognosis and causes resistance to cancer therapy. RNA sequencing and TP53 mutation data were downloaded to determine specific TP53-ass...
Autores principales: | Xu, Feng, Lin, Haoyu, He, Pei, He, Lulu, Chen, Jiexin, Lin, Ling, Chen, Yongsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051188/ https://www.ncbi.nlm.nih.gov/pubmed/32158625 http://dx.doi.org/10.1080/2162402X.2020.1731943 |
Ejemplares similares
-
DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications
por: Xu, Feng, et al.
Publicado: (2020) -
Significance of TP53 Mutational Status-Associated Signature in the Progression and Prognosis of Endometrial Carcinoma
por: Chen, Ying, et al.
Publicado: (2022) -
Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer
por: Lyu, Haoyu, et al.
Publicado: (2019) -
Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis
por: Li, He, et al.
Publicado: (2023) -
The TP53-Related Signature Predicts Immune Cell Infiltration, Therapeutic Response, and Prognosis in Patients With Esophageal Carcinoma
por: Zhang, Hongpan, et al.
Publicado: (2021)